The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model

類似資料

• Clinical relevance of nalmefene versus placebo in alcohol treatment: Reduction in mortality risk
  著者:: Roerecke, Michael, 等
  出版事項: (2015)
• Modelling the consequences of a reduction in alcohol consumption among patients with alcohol dependence based on real-life observational data
  著者:: Rahhali, Nora, 等
  出版事項: (2015)
• The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients
  著者:: François, Clément, 等
  出版事項: (2015)
• Nalmefene in alcohol‐dependent patients with a high drinking risk: Randomized controlled trial
  著者:: Miyata, Hisatsugu, 等
  出版事項: (2019)
• Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’
  著者:: Higuchi, Susumu, 等
  出版事項: (2020)